Indefinite Delivery Contract SPE2DX15D8001
- Not listed
- Dakota Drug, Inc., a small disadvantaged business, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award contract, which falls under the ECAT Generation V Program, allows Dakota Drug to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The task orders issued under this IDC indicate that Dakota Drug delivers...
- The federal Indefinite Delivery Contract (IDC) SPE2DB24D8001 was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $999,999,999.00 single-award contract covers a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support the medical supply chain operations for the U.S. Armed Forces. The contract originates from DLA Troop Support Medical's standing solicitation SPE2DH-21-R-0002 for the ECAT...
- Dakota Drug, Inc., a self-certified small disadvantaged business headquartered in Anoka, Minnesota, was awarded a single-award Indefinite Delivery Contract (IDC) by the Defense Logistics Agency under the TRICARE NORTH program with a ceiling value of $92.8 million and a period of performance extending through November 12, 2025. The contract carries a Total Small Business set-aside designation and was awarded on November 13, 2014. As the sole awardee under this vehicle, Dakota Drug serves as a...
- This indefinite delivery contract (IDC) with award number SPE2DB24D8002 was awarded by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract has a ceiling value of $999,999,999.00 and a period of performance through December 31, 2025. It is a single award IDC without any set-aside designations. The contract primarily aims to procure a wide range of pharmaceutical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as the primary vehicle for the company to deliver critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications,...
- The Defense Logistics Agency (DLA) Troop Support awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract, which runs through December 2036, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
- This indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The single-award contract, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and runs through November 2026. The contract encompasses a broad array of medical commodities including specialty...
- The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at up to $999,999,999 with a period of performance through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty...
- The Defense Logistics Agency (DLA) awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes multiple firm fixed-price delivery orders for various prescription medications, medical...
- SPE2DX15D8001Indefinite Delivery Contract
- 7.1KFederal Contract Awards
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 to Dakota Drug, Inc., a self-certified small disadvantaged business, as part of the DLA Troop Support Medical's ECAT Generation V Program. This contract allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. Under this IDC, the DLA has issued multiple firm fixed-price delivery orders to Dakota Drug, Inc. for the supply of various prescription medications, including but not limited to Trulicity, Eliquis, Januvia, Lantus, and Humira, as well as medical devices such as syringes and auto-injectors. These delivery orders, which do not have set-aside designations, are awarded to support the medical supply chain needs of the U.S. Department of Defense, with a focus on military healthcare facilities. The contract performance period extends through December 31, 2025, enabling Dakota Drug, Inc. to efficiently deliver critical medical items to defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/30/15 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DX15D8001-SPE2DX21FBQKZ | Dakota Drug, Inc. | $9 | 2/23/21 | 2/24/21 | 2/23/21 | |
Delivery Order SPE2DX15D8001-BA41 | Dakota Drug, Inc. | $3.5k | 4/3/17 | 4/4/17 | 4/3/17 | |
Delivery Order SPE2DX15D8001-SPE2DX22FBQYF | Dakota Drug, Inc. | $352 | 6/22/22 | 6/23/22 | 6/22/22 | |
Delivery Order SPE2DX15D8001-SPE2DX20FBRCY | Dakota Drug, Inc. | $2.2k | 7/9/20 | 7/30/20 | 7/9/20 | |
Delivery Order SPE2DX15D8001-BE46 | Dakota Drug, Inc. | $2.1k | 9/19/17 | 9/19/17 | 9/19/17 |